Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

ACC 2024 Congress

Catch up on all the top stories and latest evidence in cardiology research with our ACC 2024 Congress hub page.
ADVANCED SEARCH
Log in
Top
Health and Quality of Life Outcomes
Published in: Health and Quality of Life Outcomes 1/2020

01-12-2020 | Hypertension | Research

Applying SF-6D to measure health state utilities among the middle and old aged patients with hypertension in China

Authors: Xiaohan Liu, Guannan Bai, Hui Li, Shunping Li

Published in: Health and Quality of Life Outcomes | Issue 1/2020

Login to get access

Abstract

Purpose

Hypertension is a growing public health problem in China; however, little is known about health-related quality of life (HRQoL) especially health state utility (HSU) of patients with hypertension in rural China. This study aimed to examine the HSU as measured by SF-6D and to investigate its associated factors among middle and old aged patients with hypertension in rural China.

Methods

Data were collected from twelve villages in Shandong Province in 2016. SF-36 was administrated to measure HRQoL of middle and old aged patients with hypertension and was got to the SF-6D values using Hong Kong’s tariff. Descriptive analyses, such as demographic characteristics, socio-economic status, and utility, were stratified by hypertension classification. Multiple linear regression models were applied to assess the associated factors of HSU.

Results

A total of 933 (response rate:86.4%) middle and old aged patients (69.1 ± 8.2 years) with hypertension participated in the study. 39.4% of participants were male; 44.2% had stage I hypertension; 26.4% had stage II and above. The mean score of SF-6D utility score was 0.743 (SD: 0.14, range: 0.32–1.00, median: 0.756, Interquartile range:0.634–0.859). Being female (β = −0.046), having two or more comorbidities (2 vs. 1 β = −0.066; > 3 vs. 1 β = −0.098) and the health expenditure higher than 2000 RMB (2000–3999 vs.< 2000 β = −0.042; 4000–5999 vs. < 2000 β = −0.046; > 6000 vs. < 2000 β = −0.071) were significantly associated with lower SF-6D overall score; while being farmer (β = 0.032), having high household income (10,000–14,999 vs. < 5000 β = 0.045; > 15,000 vs. < 5000 β = 0.064) and having stage I and above hypertension (stage I vs. Normotensive β = 0.047; stage II vs. Normotensive β = 0.079; stage III vs. Normotensive β = 0.095) were significantly associated with higher SF-6D overall score.

Conclusion

SF-6D was capable to measure quality of life middle and old aged patients with hypertension in China. And multiple factors were demonstrated to be significantly associated with quality of life.
Literature
1.
Olsen MH, Angell SY, Asma S, et al. A call to action and a lifecourse strategy to address the global burden of raised blood pressure on current and future generations: the Lancet Commission on hypertension. Lancet (London, England). 2016;388(10060):2665–712. CrossRef
2.
Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (London, England). 2012;380(9859):2095–128. CrossRef
3.
Lu J, Lu Y, Wang X, et al. Prevalence, awareness, treatment, and control of hypertension in China: data from 1.7 million adults in a population-based screening study (China PEACE Million Persons Project). Lancet (London, England). 2017;390(10112):2549–58. CrossRef
4.
Revisol DJB, Moreira LB, Kerkhoff A, et al. Health-related quality of life and hypertension: a systematic review and meta-analysis of observational studies. J Hypertens. 2011;29(2):179–88. CrossRef
5.
Qin Y, Guo Y, Tang Y, et al. Impact of hypertension on health-related quality of life among different age subgroups in Shanghai: the subpopulation treatment effect pattern plot analysis. J Hum Hypertens. 2018;33(1):78–86. PubMedCrossRef
6.
Klocek M, Kawecka-Jaszcz K. Quality of life in patients with arterial. Hypertension. 2003;60(2):92–100.
7.
Wang R, Zhao Y, He X, et al. Impact of hypertension on health-related quality of life in a population-based study in Shanghai, China. Public health. 2009;123(8):534–9. PubMedCrossRef
8.
9.
Li H, Meng Q, Sun X, et al. Prevalence, awareness, treatment, and control of hypertension in rural China: results from Shandong Province. J Hypertens. 2010;28(3):432–8. PubMedCrossRef
10.
Peter Mfayers DM. Quality of life: the assessment, analysis and reporting of patient reported outcomes. 3rd ed. London: Wiley; 2016.
11.
Fishwick D, Lewis L, Darby A, et al. Determinants of health-related quality of life among residents with and without COPD in a historically industrialised area. Int Arch Occup Environ Health. 2014;88(6):1–7.
12.
Liu K, He L, Tang X, et al. Relationship between menopause and health-related quality of life in middle-aged Chinese women: a cross-sectional study. BMC Women’s Health. 2014;14(1):7. PubMedPubMedCentralCrossRef
13.
Yang Z, Li W, Tu X, et al. Validation and psychometric properties of Chinese version of SF-36 in patients with hypertension, coronary heart diseases, chronic gastritis and peptic ulcer. Int J Clin Pract. 2012;66(10):991–8. PubMedCrossRef
14.
Carvalho MV, Siqueira LB, Sousa AL, et al. The influence of hypertension on quality of life. Arq Bras Cardiol. 2013;100(2):164–74. PubMedCrossRef
15.
Aydemir O, Ozdemir C, Koroglu E. The impact of co-morbid conditions on the SF-36: a primary-care-based study among hypertensives. Arch Med Res. 2005;36(2):136–41. PubMedCrossRef
16.
17.
Lee MH, So ES. Impact of hypertension-related comorbidity on health-related quality of life: a population-based survey in South Korea. Asia Pac J Public Health. 2012;24(5):753–63. PubMedCrossRef
18.
Saleem F, Hassali MA, Shafie AA. A cross-sectional assessment of health-related quality of life (HRQoL) among hypertensive patients in Pakistan. Health Expect. 2014;17(3):388–95. PubMedCrossRef
19.
Zhang Y, Zhou Z, Gao J, et al. Health-related quality of life and its influencing factors for patients with hypertension: evidence from the urban and rural areas of Shaanxi Province, China. BMC Health Serv Res. 2016;16:277. PubMedPubMedCentralCrossRef
20.
Zhang L, Guo X, Zhang J, et al. Health-related quality of life among adults with and without hypertension: a population-based survey using EQ-5D in Shandong, China. Sci Rep. 2017;7(1):14960. PubMedPubMedCentralCrossRef
21.
Ekwunife OI, Aguwa CN, Igboeli NU. Health Utilities Index Mark 3 (HUI3) demonstrated construct validity in a Nigerian population with hypertension. Qual Life Res. 2013;22(2):455–8. PubMedCrossRef
22.
23.
Nguyen T-P-L, Krabbe P F M, Nguyen T-B-Y, , et al. Utilities of patients with hypertension in Northern Vietnam. PLoS ONE. 2015;10(10):e0139560. CrossRef
24.
National Bureau of Statistics of China. China Statistical Yearbook 2017 [in Chinese]. China Statistics Press, 2017.
25.
National health commission of the People's Republic of China.Circular of the Ministry of Health on the Issuance of the National Standards for 《Basic Public Health Services》(2009).
26.
Association WM. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;310(20):2191–4. CrossRef
27.
Liu LS. 2010 Chinese guidelines for the management of hypertension]. Chin J Hypertens. 2011;39(2):579–615.
28.
J. J E W, . SF-36 Health Survey: manual & interpretation guide. The health institute. Boston: New England Medical Centre; 1993.
29.
Brazier J, Roberts J, Deverill M. The estimation of a preference-based measure of health from the SF-36. J Health Econ. 2002;21(2):271–92. PubMedCrossRef
30.
31.
Sayah FA, Qiu W, Xie F, et al. Comparative performance of the EQ-5D-5L and SF-6D index scores in adults with type 2 diabetes. Qual Life Res . 2017;26(8):2057. PubMedCrossRef
32.
Mcghee SM, Brazier J, Lam CL, et al. Quality-adjusted life years: population-specific measurement of the quality component. Hong Kong Med J. 2011;17(6):17–21. PubMed
33.
Liang ZZ, Lin T, Liu T, Liu L, Binyan W. Health-related quality of life among rural men and women with hypertension: assessment by the EQ-5D-5L in Jiangsu, China. Quality Life Res. 2019;28:2069–80. CrossRef
34.
Wen L, Qinghua Z, Wunong Z, et al. Current status of active aging of 381 rural seniors and its influence factors. J Nurs (China). 2019;26(15):41–5.
35.
Liu Z, Albanese E, Li S, et al. Chronic disease prevalence and care among the elderly in urban and rural Beijing, China: a 10/66 Dementia Research Group cross-sectional survey. BMC Public Health. 2009;9(1):394. PubMedPubMedCentralCrossRef
36.
Qian S. Aging and separation from children: The health implications of adult migration for elderly parents in rural China. Demograp Res. 2019;37:1761–92.
37.
Xiaobo W, Liqin W, Dianwu L, et al. Analysis on hypertension KAP and influence factors in rural population. China J Public Health. 2008;24(3):269–70.
38.
Li D, Lv J, Liu F, et al. Hypertension burden and control in mainland China: analysis of nationwide data 2003–2012. Int J Cardiol. 2015;184:637–44. PubMedCrossRef
39.
Wong CKH, Mulhern B. SF-6D population norms for the Hong Kong Chinese general population. Qual Life Res. 2018;27(9):2349–59. PubMedCrossRef
40.
Ferreira LN, Ferreira PL, Pereira LN, et al. Exploring the consistency of the SF-6D. Value Health. 2013;16(6):1023–31. PubMedCrossRef
41.
Zhou ZL, Zhou ZY, Dan LI. Analyzing the Health-related quality of life of urban and rural residents in Shaanxi: estimation based on the EQ-5D value sets . Chin Health Econ. 2015;34(2):13–6.
42.
Andrade JM, Rios LR, Teixeira LS, et al. Influence of socioeconomic factors on the quality of life of elderly hypertensive individuals] . Ciencia saude coletiva. 2014;19(8):3497–504. PubMedCrossRef
43.
Bardage C, Isacson DG. Hypertension and health-related quality of life. An epidemiological study in Sweden. J Clin Epidemiol. 2001;54(2):172–81. PubMedCrossRef
44.
Pan Y, Ying YE, Zhu J, et al. Analysis of influencing factors on quality of life(QOL) of patients with hypertension by SF-36 scale. Fudan Univ J Med Sci. 2014;41(2):205–9.
45.
Arslantas D, Ayranci U, Unsal A, et al. Prevalence of hypertension among individuals aged 50 years and over and its impact on health related quality of life in a semi-rural area of western Turkey . Chin Med J. 2008;121(16):1524–31. PubMedCrossRef
46.
Monsca L, Appel LJ, Benjamin EJEA. Evidence-based guidelines for cardiovascular disease prevention in women. American Heart Association scientific statement. Arterioscler Thromb Vasc Biol. 2004;24(3):29–50.
Metadata
Title
Applying SF-6D to measure health state utilities among the middle and old aged patients with hypertension in China
Authors
Xiaohan Liu
Guannan Bai
Hui Li
Shunping Li
Publication date
01-12-2020
Publisher
BioMed Central
Published in
Health and Quality of Life Outcomes / Issue 1/2020
Electronic ISSN: 1477-7525
DOI
https://doi.org/10.1186/s12955-020-01598-4

Other articles of this Issue 1/2020

Health and Quality of Life Outcomes 1/2020 Go to the issue

Research

Psychometric evaluation of a Canadian version of the Seattle Angina Questionnaire (SAQ-CAN)

Research

The adaptation of sport assessment-patella questionnaire into simplified Chinese version: cross-cultural adaptation, reliability and validity

Research

Validation of subscales of the Severe Asthma Questionnaire (SAQ) using exploratory factor analysis (EFA)

Review

Measuring quality of life in Duchenne muscular dystrophy: a systematic review of the content and structural validity of commonly used instruments

Research

Effects of stigma, hope and social support on quality of life among Chinese patients diagnosed with oral cancer: a cross-sectional study

Correction

Correction to: Health-related quality of life measured using the EQ-5D-5 L: population norms for the capital of Iran